Literature DB >> 25068542

The origins of cyanobactin chemistry and biology.

Marcel Jaspars1.   

Abstract

The correct structure of the symmetrical cyanobactin, ascidiacyclamide, was published in Chemical Communications by Hamamoto et al. in 1983. The cyanobactin family of compounds are cyclic peptides with modifications including azole/azoline rings, D-stereocentres and in some cases prenyl groups. Although related compounds were isolated earlier by Ireland et al., two of the three published structures later had to be corrected. Hamamoto's ascidiacyclamide structure assisted the understanding of the chemistry, bioactivity, biological origin and biosynthesis of this group of compounds. Cyanobactins are of interest as new chemotypes for the treatment of a range of diseases, in particular those in which extended binding sites are implicated.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25068542     DOI: 10.1039/c3cc49252d

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  10 in total

Review 1.  The manifold roles of microbial ribosomal peptide-based natural products in physiology and ecology.

Authors:  Yanyan Li; Sylvie Rebuffat
Journal:  J Biol Chem       Date:  2019-11-29       Impact factor: 5.157

2.  Enzymatic Macrocyclization of 1,2,3-Triazole Peptide Mimetics.

Authors:  Emilia Oueis; Marcel Jaspars; Nicholas J Westwood; James H Naismith
Journal:  Angew Chem Weinheim Bergstr Ger       Date:  2016-04-05

3.  Enzymatic Macrocyclization of 1,2,3-Triazole Peptide Mimetics.

Authors:  Emilia Oueis; Marcel Jaspars; Nicholas J Westwood; James H Naismith
Journal:  Angew Chem Int Ed Engl       Date:  2016-04-05       Impact factor: 15.336

4.  Synthesis of Hybrid Cyclopeptides through Enzymatic Macrocyclization.

Authors:  Emilia Oueis; Brunello Nardone; Marcel Jaspars; Nicholas J Westwood; James H Naismith
Journal:  ChemistryOpen       Date:  2016-12-13       Impact factor: 2.911

5.  Trikoramides B-D, Bioactive Cyanobactins from the Marine Cyanobacterium Symploca hydnoides.

Authors:  Ma Yadanar Phyo; Teo Min Ben Goh; Jun Xian Goh; Lik Tong Tan
Journal:  Mar Drugs       Date:  2021-09-28       Impact factor: 5.118

Review 6.  Marine Bacterial Ribosomal Peptides: Recent Genomics- and Synthetic Biology-Based Discoveries and Biosynthetic Studies.

Authors:  Linda Sukmarini
Journal:  Mar Drugs       Date:  2022-08-24       Impact factor: 6.085

Review 7.  Cyanobactins from Cyanobacteria: Current Genetic and Chemical State of Knowledge.

Authors:  Joana Martins; Vitor Vasconcelos
Journal:  Mar Drugs       Date:  2015-11-13       Impact factor: 5.118

8.  Derivatisable Cyanobactin Analogues: A Semisynthetic Approach.

Authors:  Emilia Oueis; Catherine Adamson; Greg Mann; Hannes Ludewig; Philip Redpath; Marie Migaud; Nicholas J Westwood; James H Naismith
Journal:  Chembiochem       Date:  2015-11-10       Impact factor: 3.164

Review 9.  Cyclic Peptides: Promising Scaffolds for Biopharmaceuticals.

Authors:  Donghyeok Gang; Do Wook Kim; Hee-Sung Park
Journal:  Genes (Basel)       Date:  2018-11-16       Impact factor: 4.096

10.  Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations.

Authors:  Samira Soltani; Riadh Hammami; Paul D Cotter; Sylvie Rebuffat; Laila Ben Said; Hélène Gaudreau; François Bédard; Eric Biron; Djamel Drider; Ismail Fliss
Journal:  FEMS Microbiol Rev       Date:  2021-01-08       Impact factor: 16.408

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.